- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 14, 2025 | 28.33M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 26.35M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 24.65M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 21.98M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 21.76M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$8.15M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$8M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $120K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $738K |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$20.09M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$25.5M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$5.51M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $8.84M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $17.28M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $27.81M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $31.25M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $40.96M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $65.31M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $53.68M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $134.33M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $123.85M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $10.6M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $20.56M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $114.24M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $132.68M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.88 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.74 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.73 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$2.05 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.88 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.74 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.73 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$2.05 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $9.31M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $36.2M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $12.65M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $42.59M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $4.6M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $11.68M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $3.92M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $13.56M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$23.08M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$67.35M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$24.52M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$19.75M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$16.1M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$44.6M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$6.49M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$22.01M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$12.9M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$39.25M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$11.53M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$29.08M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $3.9M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $12.7M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $3.88M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $7.65M |
| Revenue | Q3 2025 · Sep 30, 2025 | $5.28M |
| Revenue | Q3 2025 · Sep 30, 2025 | $22.45M |
| Revenue | Q3 2025 · Sep 30, 2024 | $9.3M |
| Revenue | Q3 2025 · Sep 30, 2024 | $36.09M |
| Capex restated | Q3 2025 · Sep 30, 2024 | $70K |